New Key Statistics Module, Z-Score and F-Score
NAS:NRIX Key Ratios
Market Cap $ M | 754.79 |
Enterprise Value $ M | 539.96 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 3.60 |
Price/Sales | 8.33 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 80.00 |
EPS (TTM) $ | -2.66 |
Beneish M-Score | -3.14 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -43.50 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -3.43 |
EV-to-EBITDA | -3.78 |
PEG | -- |
Shares Outstanding M | 61.07 |
Net Margin (%) | -178.93 |
Operating Margin % | -194.51 |
Pre-tax Margin (%) | -178.82 |
Quick Ratio | 2.86 |
Current Ratio | 2.86 |
ROA % (ttm) | -42.64 |
ROE % (ttm) | -63.65 |
ROIC % (ttm) | -129.39 |
Dividend Yield % | -- |
Altman Z-Score | -0.12 |
NRIX Number of Guru Trades
NRIX Volume of Guru Trades
Gurus Latest Trades with NAS:NRIX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:NRIX is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Nurix Therapeutics Inc Insider Transactions
No Available Data
News about NAS:NRIX
Total 0- 1